Palantir Stock Is Taking a Hit: These Key Figures From the AI Company's Earnings Report Highlight Why I'm Still Not Buying

Palantir reported Q1 revenue growth of 85% year over year to $1.63 billion and raised 2026 revenue guidance to a midpoint of $7.66 billion, implying 71% growth, but the stock fell almost 7% on concerns about valuation and slowing forward metrics. Closed TCV growth decelerated sharply to 61% from 138% in Q4, while U.S. commercial RDV growth slowed for a third straight quarter. Despite strong operating margin at 60%, the stock remains expensive at roughly 60x trailing sales and around 150x earnings.

Analysis

The market is likely punishing not just a rich multiple, but the first real sign that Palantir’s growth algorithm may be shifting from scarce-supply upside to execution-constrained normalization. When a software name is valued like a scarce AI infrastructure proxy, any slowdown in bookings quality matters more than reported revenue because it reprices the terminal duration of the growth story, not just next quarter’s print. The key second-order effect is that shorter contract duration can inflate current revenue while quietly reducing future visibility, which is exactly the kind of mix shift that gets masked in headline acceleration.

The more important read-through is for AI-adjacent software and systems integrators: if enterprise buyers are still enthusiastic but contracting shorter, the bottleneck is increasingly deployment capacity and procurement caution rather than demand creation. That tends to favor companies that monetize picks-and-shovels integration, data plumbing, and workflow transformation over single-platform narrative names. It also argues for skepticism toward any AI stock whose valuation assumes both rapid adoption and widening deal duration at the same time.

Risk to the short thesis is that Palantir can sustain revenue growth for several quarters even with softer bookings if backlog conversion remains strong and U.S. demand is genuinely supply-constrained. The reversal trigger would be another quarter of re-acceleration in closed TCV or a clear inflection in dollar-weighted duration, which would re-open the path to a narrative-driven squeeze. But absent that, the stock is vulnerable to multiple compression over the next 1-3 months as investors realize 70% guidance may still be too high if contract quality keeps deteriorating.

The contrarian point is that consensus may be underestimating how long this company can compound inside a premium multiple regime if it keeps producing 50%+ operating margins and triple-digit U.S. growth. That said, the current setup is asymmetric: the stock does not need a collapse in fundamentals to re-rate lower, only a pause in acceleration. In other words, the burden of proof has shifted from bears needing to show decay to bulls needing to prove the next leg of acceleration is still intact.

Key Decisions for Investors

• Short PLTR on a 1-3 month horizon via common or puts; target a 15-25% downside move if bookings normalization continues and the multiple compresses from low-60s P/S toward the high-40s.
• Use a bear call spread in PLTR for defined risk; structure around a post-earnings volatility crush and finance the trade with the assumption that revenue upside is already partially priced in.
• Pair trade: long AI-enablement/integration exposure vs short PLTR over 2-4 quarters, favoring names that benefit from implementation spend rather than pure narrative premium; the trade works if enterprise AI budgets shift from platform enthusiasm to deployment execution.
• Avoid buying the dip outright until a second consecutive quarter shows re-acceleration in closed TCV or RDV trend stabilization; the risk/reward is poor while forward visibility is softening.
• For tactical traders, consider selling into any squeeze back toward prior support rather than averaging down short immediately; PLTR can rally hard on narrative, but the next catalyst likely needs booking quality improvement, not just guidance confidence.